Literature DB >> 31757767

Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies.

Xueyong Zhu1, Hannah L Turner1, Shanshan Lang1, Ryan McBride2, Sandhya Bangaru3, Iuliia M Gilchuk3, Wenli Yu1, James C Paulson2, James E Crowe4, Andrew B Ward5, Ian A Wilson6.   

Abstract

n class="Species">Influenza virus neuraminidase (NA) is a major target for small-molecule antiviral drugs. Antibodies targeting the NA surface antigen could also inhibit virus entry and egress to provide host protection. However, our understanding of the nature and range of target epitopes is limited because of a lack of human antibody structures with influenza neuraminidase. Here, we describe crystal and cryogenic electron microscopy (cryo-EM) structures of NAs from human-infecting avian H7N9 viruses in complex with five human anti-N9 antibodies, systematically defining several antigenic sites and antibody epitope footprints. These antibodies either fully or partially block the NA active site or bind to epitopes distant from the active site while still showing neuraminidase inhibition. The inhibition of antibodies to NAs was further analyzed by glycan array and solution-based NA activity assays. Together, these structural studies provide insights into protection by anti-NA antibodies and templates for the development of NA-based influenza virus vaccines and therapeutics.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  H7N9 influenza virus; X-ray crystallography; antibody; cryo-electron microscopy; glycan array; inhibition mechanism; neuraminidase; neuraminidase-Fab structures

Mesh:

Substances:

Year:  2019        PMID: 31757767      PMCID: PMC6908751          DOI: 10.1016/j.chom.2019.10.002

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  49 in total

1.  Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.

Authors:  Minsun Hong; Peter S Lee; Ryan M B Hoffman; Xueyong Zhu; Jens C Krause; Nick S Laursen; Sung-Il Yoon; Langzhou Song; Lynda Tussey; James E Crowe; Andrew B Ward; Ian A Wilson
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  Likelihood-enhanced fast translation functions.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Laurent C Storoni; Randy J Read
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-03-24

3.  The influenza virus resource at the National Center for Biotechnology Information.

Authors:  Yiming Bao; Pavel Bolotov; Dmitry Dernovoy; Boris Kiryutin; Leonid Zaslavsky; Tatiana Tatusova; Jim Ostell; David Lipman
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

4.  Computational design of proteins targeting the conserved stem region of influenza hemagglutinin.

Authors:  Sarel J Fleishman; Timothy A Whitehead; Damian C Ekiert; Cyrille Dreyfus; Jacob E Corn; Eva-Maria Strauch; Ian A Wilson; David Baker
Journal:  Science       Date:  2011-05-13       Impact factor: 47.728

5.  A small-molecule fusion inhibitor of influenza virus is orally active in mice.

Authors:  Maria J P van Dongen; Rameshwar U Kadam; Jarek Juraszek; Edward Lawson; Boerries Brandenburg; Frederike Schmitz; Wim B G Schepens; Bart Stoops; Harry A van Diepen; Mandy Jongeneelen; Chan Tang; Jan Vermond; Alida van Eijgen-Obregoso Real; Sven Blokland; Divita Garg; Wenli Yu; Wouter Goutier; Ellen Lanckacker; Jaco M Klap; Daniëlle C G Peeters; Jin Wu; Christophe Buyck; Tim H M Jonckers; Dirk Roymans; Peter Roevens; Ronald Vogels; Wouter Koudstaal; Robert H E Friesen; Pierre Raboisson; Dashyant Dhanak; Jaap Goudsmit; Ian A Wilson
Journal:  Science       Date:  2019-03-08       Impact factor: 47.728

6.  Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site.

Authors:  Xueyong Zhu; Hua Yang; Zhu Guo; Wenli Yu; Paul J Carney; Yan Li; Li-Mei Chen; James C Paulson; Ruben O Donis; Suxiang Tong; James Stevens; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

7.  An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.

Authors:  Lalitha Venkatramani; Elena Bochkareva; Janis T Lee; Upma Gulati; W Graeme Laver; Alexey Bochkarev; Gillian M Air
Journal:  J Mol Biol       Date:  2005-12-07       Impact factor: 5.469

8.  Human infection with a novel avian-origin influenza A (H7N9) virus.

Authors:  Rongbao Gao; Bin Cao; Yunwen Hu; Zijian Feng; Dayan Wang; Wanfu Hu; Jian Chen; Zhijun Jie; Haibo Qiu; Ke Xu; Xuewei Xu; Hongzhou Lu; Wenfei Zhu; Zhancheng Gao; Nijuan Xiang; Yinzhong Shen; Zebao He; Yong Gu; Zhiyong Zhang; Yi Yang; Xiang Zhao; Lei Zhou; Xiaodan Li; Shumei Zou; Ye Zhang; Xiyan Li; Lei Yang; Junfeng Guo; Jie Dong; Qun Li; Libo Dong; Yun Zhu; Tian Bai; Shiwen Wang; Pei Hao; Weizhong Yang; Yanping Zhang; Jun Han; Hongjie Yu; Dexin Li; George F Gao; Guizhen Wu; Yu Wang; Zhenghong Yuan; Yuelong Shu
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

9.  Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.

Authors:  Hongquan Wan; Hua Yang; David A Shore; Rebecca J Garten; Laura Couzens; Jin Gao; Lianlian Jiang; Paul J Carney; Julie Villanueva; James Stevens; Maryna C Eichelberger
Journal:  Nat Commun       Date:  2015-02-10       Impact factor: 14.919

Review 10.  NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

Authors:  Florian Krammer; Ron A M Fouchier; Maryna C Eichelberger; Richard J Webby; Kathryn Shaw-Saliba; Hongquan Wan; Patrick C Wilson; Richard W Compans; Ioanna Skountzou; Arnold S Monto
Journal:  mBio       Date:  2018-04-03       Impact factor: 7.867

View more
  23 in total

1.  Evolution and Antigenic Advancement of N2 Neuraminidase of Swine Influenza A Viruses Circulating in the United States following Two Separate Introductions from Human Seasonal Viruses.

Authors:  Bryan S Kaplan; Tavis K Anderson; Jennifer Chang; Jefferson Santos; Daniel Perez; Nicola Lewis; Amy L Vincent
Journal:  J Virol       Date:  2021-08-11       Impact factor: 5.103

2.  Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface.

Authors:  Xueyong Zhu; Julianna Han; Weina Sun; Eduard Puente-Massaguer; Wenli Yu; Peter Palese; Florian Krammer; Andrew B Ward; Ian A Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-20       Impact factor: 12.779

3.  Antigenic comparison of the neuraminidases from recent influenza A vaccine viruses and 2019-2020 circulating strains.

Authors:  Jin Gao; Xing Li; Laura Klenow; Tahir Malik; Hongquan Wan; Zhiping Ye; Robert Daniels
Journal:  NPJ Vaccines       Date:  2022-07-14       Impact factor: 9.399

4.  Librator: a platform for the optimized analysis, design, and expression of mutable influenza viral antigens.

Authors:  Lei Li; Siriruk Changrob; Yanbin Fu; Olivia Stovicek; Jenna J Guthmiller; Joshua J C McGrath; Haley L Dugan; Christopher T Stamper; Nai-Ying Zheng; Min Huang; Patrick C Wilson
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 13.994

5.  Antigenic evolution of human influenza H3N2 neuraminidase is constrained by charge balancing.

Authors:  Yiquan Wang; Ruipeng Lei; Armita Nourmohammad; Nicholas C Wu
Journal:  Elife       Date:  2021-12-08       Impact factor: 8.140

6.  Analysis of the Evolution of Pandemic Influenza A(H1N1) Virus Neuraminidase Reveals Entanglement of Different Phenotypic Characteristics.

Authors:  Meiling Dai; Wenjuan Du; Carles Martínez-Romero; Tim Leenders; Tom Wennekes; Guus F Rimmelzwaan; Frank J M van Kuppeveld; Ron A M Fouchier; Adolfo Garcia-Sastre; Erik de Vries; Cornelis A M de Haan
Journal:  mBio       Date:  2021-05-11       Impact factor: 7.867

Review 7.  Host immune response-inspired development of the influenza vaccine.

Authors:  Angela Choi; Adolfo García-Sastre; Michael Schotsaert
Journal:  Ann Allergy Asthma Immunol       Date:  2020-04-20       Impact factor: 6.347

8.  Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective.

Authors:  Anders Madsen; Ya-Nan Dai; Meagan McMahon; Aaron J Schmitz; Jackson S Turner; Jessica Tan; Tingting Lei; Wafaa B Alsoussi; Shirin Strohmeier; Mostafa Amor; Bassem M Mohammed; Philip A Mudd; Viviana Simon; Rebecca J Cox; Daved H Fremont; Florian Krammer; Ali H Ellebedy
Journal:  Immunity       Date:  2020-09-24       Impact factor: 31.745

9.  Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.

Authors:  Amanda L Skarlupka; Anne-Gaelle Bebin-Blackwell; Spencer F Sumner; Ted M Ross
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

10.  Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice.

Authors:  Iuliia M Gilchuk; Sandhya Bangaru; Pavlo Gilchuk; Ryan P Irving; Nurgun Kose; Robin G Bombardi; Natalie J Thornburg; C Buddy Creech; Kathryn M Edwards; Sheng Li; Hannah L Turner; Wenli Yu; Xueyong Zhu; Ian A Wilson; Andrew B Ward; James E Crowe
Journal:  Cell Host Microbe       Date:  2019-11-19       Impact factor: 31.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.